人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
2020《中国学术期刊影响因子年报》统计源期刊

新发传染病电子杂志 ›› 2020, Vol. 5 ›› Issue (3): 195-197.doi: 10.19871/j.cnki.xfcrbzz.2020.03.012

• 论著 • 上一篇    下一篇

含多替拉韦方案治疗人类免疫缺陷病毒急性感染1例并文献复习

蒙志好1, 覃善芳1, 刘爱梅1, 沈银忠2   

  1. 1.广西壮族自治区龙潭医院感染科,广西 柳州 545005;
    2.上海市公共卫生临床中心感染和免疫科,上海 201508
  • 收稿日期:2019-09-18 出版日期:2020-03-20 发布日期:2020-10-12
  • 通讯作者: 沈银忠,Email: shenyinzhong@shphc.org.cn
  • 基金资助:
    1.国家科技重大专项(2017ZX10202101-002-002);2.广西壮族自治区卫生健康委重点课题(重2011067);3.广西科学研究与技术开发计划项目(桂科攻1598011-9)

Dolutegravir for rapid viral suppression in acute HIV infection

Meng Zhihao1, Qin Shanfang1, Liu Aimei1, Shen Yinzhong2   

  1. 1. Department of Infectious Disease, Longtan Hospital of Guangxi Autonomous Region, Guangxi Liuzhou 545005, China;
    2. Department of Infectious and Immunology Disease, Public Health Clinical Center, Shanghai 201508, China
  • Received:2019-09-18 Online:2020-03-20 Published:2020-10-12

摘要: 目的 探讨人类免疫缺陷病毒(HIV)急性感染的早期诊断和治疗方法。方法 对1例HIV急性感染者的临床表现、诊疗经过和预后情况进行分析。结果 患者高危行为1周后出现发热、乏力、头痛等症状,15d后HIV抗体初筛试验阳性,确认试验不确定,HIV-1RNA 8 847 000拷贝/ml,CD4+T淋巴细胞计数173/mm3,诊断HIV急性感染,给予替诺福韦+拉米夫定+多替拉韦的方案抗病毒治疗,4周后HIV-1 RNA3303拷贝/ml,3个月HIV-1 DNA150拷贝/百万细胞,6个月CD4+T淋巴细胞计数530/mm3,HIV-1 RNA75拷贝/ml。结论 及时进行RNA检测对HIV-1急性感染的诊断有极大帮助,使用含整合酶抑制剂方案进行治疗,可以快速有效降低病毒载量,提升CD4+T淋巴细胞数量,降低HIV-1 DNA到极低水平。

关键词: 急性人类免疫缺陷病毒感染, 整合酶抑制剂, 多替拉韦

Abstract: Objective To explore the early diagnosis and treatment for acute HIV infection. Methods A patient with acute HIV infection were analyzed in the aspect of clinical manifestations, treatment course and prognosis. Results One week after high-risk behavior, the patient developed fever, fatigue, headache, etc. 15 days later, this patient's HIV antibody screening test was positive, but confirmation test was uncertain. This patient's HIV-1 RNA was 8 847 000 copies/ml with CD4+T cell count of 173/mm3, indicating the diagnosis of acute HIV infection. TDF+3TC+DTG regimen was given as initial antiviral treatment. After 4 weeks, HIV-1 RNA was 3303 copies/ml and was dropped to 150copies/million cells after 3 months. After 6 months of antiviral treatment, CD4+T cell count was increased to 530/mm3 with viral load decreased to 75copies/ml. Conclusion RNA testing is helpful for the diagnosis of acute HIV-1 infection. Early initiation of antiviral therapy with Integrase Inhibitor during acute HIV infection stage can rapidly reduce the viral load, enhance CD4+T cells recovery and reduce the HIV-1 DNA load to an extremely low level.

Key words: Acute human immunodeficiency virus infection, Integrase Inhibitor, Dolutegravir